The largest database of trusted experimental protocols

Jmp version 5.0.1a

Manufactured by SAS Institute
Sourced in United States

JMP version 5.0.1a is a data analysis software product developed by SAS Institute. It provides users with tools for data visualization, exploration, and statistical analysis. The core function of JMP is to enable data-driven decision making through intuitive graphical interfaces and a wide range of analytical capabilities.

Automatically generated - may contain errors

Lab products found in correlation

4 protocols using jmp version 5.0.1a

1

Exploring Tolvaptan Pharmacokinetics and Outcomes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The sample size was not calculated because this study was exploratory. Data were expressed as the mean ± standard deviation or median (interquartile range; IQR).
We conducted a statistical analysis using Pearson's correlation coefficient and multiple regression analysis to investigate the relationships between clinical outcome and patients' baseline characteristics, including tolvaptan concentration, as well as the relationships among PK parameters. Specifically, we utilized Pearson's correlation coefficient to assess the linear relationship between two continuous variables and to evaluate the strength and direction of the association between our variables of interest. Given that our variables were measured on a continuous scale, this test was selected for our analysis. Multiple regression analysis was performed to determine which covariates significantly influenced the clinical outcome. The method used to select the variables in the model was a stepwise selection. The significance level of the score of entering an effect into the model was .20. Independent predictive variables with p values of less than .05 were considered statistically significant. Overall, the selection of these statistical tests was based on the nature of our research questions and the types of variables we were examining. Data were analyzed using JMP version 5.0.1a (SAS).
+ Open protocol
+ Expand
2

Parkinson's Disease Neuroimaging Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Statistical analysis of the data was performed using JMP version 5.0.1a (SAS Institute Inc., North Carolina, USA). Pearson's chi-squared test and the nonparametric Mann–Whitney U test were used for between subgroup comparisons of categorical data (gender ratio and the prevalence of motor complications, hallucination, depression, anxiety, and orthostatic hypotension), and age (years), disease duration (years), MDS-UPDRS score (points), dosage of antiparkinsonian drugs (LED, levodopa equivalent dose[23 (link)], mg), and Hoehn and Yahr stage [24 (link)]. Spearman's rank correlation coefficient was used to test for correlations between SPECT changes (rCBF change index (% points)) and motor improvement (Motor Improvement Index), and between dosage of antiparkinsonian drugs (LED, mg) and motor improvement (Motor Improvement Index). The Wilcoxon signed-rank test was used to evaluate motor performance (MDS-UPDRS part III score (points)) in the off-stage versus in the on-stage, and rCBF (Extent (%)) in the off-stage versus in the on-stage. The level of significance was set at p < 0.05.
+ Open protocol
+ Expand
3

Statistical Analysis of Ordinal Data

Check if the same lab product or an alternative is used in the 5 most similar protocols
Statistical analyses were carried out with GraphPad Prism 5.02 software (GraphPad Software Inc., San Diego, CA, USA) and JMP version 5.0.1a (SAS Institute, Cary, NC, USA). Data are presented as the mean ± standard deviation, unless otherwise indicated. The Wilcoxon signed‐rank test was used to evaluate differences in ordinal data between two groups. < 0.05 was considered to show statistical significance.
+ Open protocol
+ Expand
4

Irinotecan Efficacy by Tumor Type

Check if the same lab product or an alternative is used in the 5 most similar protocols
Oncology Group Performance Status (0-1 vs. ≥2), primary organ of neoplasms, combination with other anti-cancer agents, planned initial dose and interval of irinotecan were reviewed and analyzed using logistic regression models. For all analyses, p<0.05 was defined as statistically significant. All statistical analyses were performed using JMP version 5.01a (SAS Inc., Cary, NC, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!